Back

Hybrid CTA/PET imaging of coronary artery disease in non-diabetic, prediabetic and diabetic patients evaluated for chest pain

10 May 2023 (17:12 - 17:21)
Organised by:
Congress Presentation Part of: The trio of imaging, fibrosis and perfusion Hybrid and Fusion Imaging EACVI Premium Access EACVI 2023

About the speaker

Photo
Doctor Teemu Maaniitty

University of Turku, Turku (Finland)

5 More presentations in this session

Presentation thumbnail
Non-infarcted myocardium inflammation predicts outcomes after myocardial infarction
Doctor A. Pavon (Lugano, CH)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic value of stress CMR imaging to evaluate stable chest pain: a twenty-year meta-analysis
Doctor G. Bisaccia (Chieti, IT)
Abstract Slides Video
Presentation thumbnail
Polygenic risk scores in predicting the presence of coronary artery disease in symptomatic patients - A validation study utilizing an accurate phenotype based on state-of-the-art imaging.
Doctor I. Kujala (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study in ischemic cardiomyopathy: international DERIVATE-ICM Registry
Doctor L. Fusini (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Safety and incremental prognostic value of stress CMR in patients with known chronic kidney disease
Doctor T. Pezel (Paris, FR)
Abstract Slides

Access the full session

Session thumbnail
The trio of imaging, fibrosis and perfusion
Video

The Event

Event poster

EACVI 2023

10 May 2023 17:12 CET
You may be interested in
thumbnail
Congress Session
Novel non-invasive imaging of coronary artery disease
thumbnail
Congress Session
Risk prediction in coronary artery disease using cardiac computed tomography
thumbnail
Congress Presentation
Impact of the coronary artery calcium score on the cardiovascular preventive management of asymptomatic patients with diabetes.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources